UNSPSC 51384600: Nonsteroidal anti inflammatory pyrazoles

Nonsteroidal anti inflammatory drugs made from azoles of two nitrogens at the 1,2 positions, next to each other.

UNSPSC 51384600 Nonsteroidal anti-inflammatory pyrazoles is a Class code that does not align with the recent state and local contract opportunities posted under it. The three most recent solicitations—from Seminole County, Florida; the Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP)—involve naloxone procurement, direct-to-manufacturer pharmacy programs, and generic multi-source pharmaceuticals and over-the-counter products respectively. None of these opportunities involve nonsteroidal anti-inflammatory pyrazoles, which are a specific class of pain-relief medications. The mismatch suggests either a data-classification error in how these opportunities were tagged or limited recent activity under the code's actual therapeutic scope.

The three posted opportunities reflect state health and human services agencies, county health departments, and cooperative purchasing consortiums seeking pharmaceutical supply contracts. Seminole County's IFB 60459723LAS solicits 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries beginning in 2023 and a two-year initial term plus one-year renewal option; Texas HHS issued RFI HHS0017013 in April 2026 to explore direct-to-manufacturer prescription models; and MMCAP's RFP S1070000015802, due March 26, 2026, establishes cooperative contracts for generic pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, requiring distribution through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with awards effective July 1, 2026. The code shows little relevant recent activity aligned with its stated pharmaceutical category.